- Home
- VHI vs ALT Comparison
VHI vs ALT Comparison
Compare VHI & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHI
- ALT
- Stock Information
- Founded
- VHI 1932
- ALT 1997
- Country
- VHI United States
- ALT United States
- Employees
- VHI N/A
- ALT N/A
- Industry
- VHI Major Chemicals
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- VHI Industrials
- ALT Health Care
- Exchange
- VHI Nasdaq
- ALT Nasdaq
- Market Cap
- VHI 453.6M
- ALT 472.3M
- IPO Year
- VHI N/A
- ALT N/A
- Fundamental
- Price
- VHI $17.74
- ALT $5.59
- Analyst Decision
- VHI Sell
- ALT Strong Buy
- Analyst Count
- VHI 1
- ALT 7
- Target Price
- VHI $20.00
- ALT $21.00
- AVG Volume (30 Days)
- VHI 9.3K
- ALT 2.0M
- Earning Date
- VHI 05-08-2025
- ALT 05-13-2025
- Dividend Yield
- VHI 1.77%
- ALT N/A
- EPS Growth
- VHI 4465.30
- ALT N/A
- EPS
- VHI 4.11
- ALT N/A
- Revenue
- VHI $2,101,400,000.00
- ALT $20,000.00
- Revenue This Year
- VHI $22.20
- ALT N/A
- Revenue Next Year
- VHI $7.66
- ALT N/A
- P/E Ratio
- VHI $4.41
- ALT N/A
- Revenue Growth
- VHI 6.57
- ALT N/A
- 52 Week Low
- VHI $14.20
- ALT $3.55
- 52 Week High
- VHI $41.75
- ALT $11.16
- Technical
- Relative Strength Index (RSI)
- VHI 57.48
- ALT 56.67
- Support Level
- VHI $16.75
- ALT $4.95
- Resistance Level
- VHI $18.43
- ALT $6.05
- Average True Range (ATR)
- VHI 0.63
- ALT 0.37
- MACD
- VHI 0.21
- ALT 0.10
- Stochastic Oscillator
- VHI 75.30
- ALT 65.67
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.